{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:05:30Z","timestamp":1789398330953,"version":"build-2803163510"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073893"],"award-info":[{"award-number":["82073893"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2022JJ20095"],"award-info":[{"award-number":["2022JJ20095"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Many survivors of a first primary cancer (FPCs) are at risk of developing a second primary cancer (SPC), with effects on patient prognosis. Primary cancers have different frequencies of specific SPC development and the development of SPCs may be closely related to the FPC. The aim of this study was to explore possible correlations between SPCs and FPCs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Relevant literature on SPCs was retrospectively searched and screened from four databases, namely, PubMed, EMBASE, Web of Science, and PMC. Data on the number of patients with SPC in 28 different organ sites were also collected from The Surveillance, Epidemiology, and End Results (SEER) 8 Registry and NHANES database.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 9 617 643 patients with an FPC and 677 430 patients with an SPC were included in the meta-analysis. Patients with a first primary gynaecological cancer and thyroid cancer frequently developed a second primary breast cancer and colorectal cancer. Moreover, those with a first primary head and neck cancer, anal cancer and oesophageal cancer developed a second primary lung cancer more frequently. A second primary lung cancer and prostate cancer was also common among patients with first primary bladder cancer and penile cancer. Patients with second primary bladder cancer accounted for 56% of first primary ureteral cancer patients with SPCs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study recommends close clinical follow-up, monitoring and appropriate interventions in patients with relevant FPCs for better screening and early diagnosis of SPCs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjs\/znad377","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T05:47:42Z","timestamp":1701928062000},"source":"Crossref","is-referenced-by-count":35,"title":["Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients"],"prefix":"10.1093","volume":"111","author":[{"given":"Xinyu","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Oncology, Zhujiang Hospital, Southern Medical University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyuan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhujiang Hospital, Southern Medical University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueming","family":"Ju","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China , Chengdu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhujiang Hospital, Southern Medical University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozheng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhujiang Hospital, Southern Medical University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhujiang Hospital, Southern Medical University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaoqu","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics , Beijing , China"},{"name":"Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bufu","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Zhongshan Hospital, Fudan University , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2401-5349","authenticated-orcid":false,"given":"Quan","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Xiangya Hospital, Central South University , Changsha , P. R. China"},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University , Hunan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3198-7568","authenticated-orcid":false,"given":"Youyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China , Chengdu , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7217-0111","authenticated-orcid":false,"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhujiang Hospital, Southern Medical University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8215-2045","authenticated-orcid":false,"given":"Peng","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Oncology, Zhujiang Hospital, Southern Medical University , Guangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"key":"2024022400024408200_znad377-B1"},{"key":"2024022400024408200_znad377-B2","doi-asserted-by":"crossref","first-page":"e000172","DOI":"10.1136\/esmoopen-2017-000172","article-title":"Multiple primary tumours: challenges and approaches, a review","volume":"2","author":"Vogt","year":"2017","journal-title":"ESMO Open"},{"key":"2024022400024408200_znad377-B3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0360-3016(98)00250-8","article-title":"Second primary tumours in laryngeal cancer: results of long-term follow-up","volume":"42","author":"Narayana","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024022400024408200_znad377-B4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"de Gonzalez A","year":"2011","journal-title":"Lancet Oncol"},{"key":"2024022400024408200_znad377-B5","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.21873\/anticanres.11548","article-title":"Second primary malignancy in bladder carcinoma\u2014a population-based study","volume":"37","author":"Khanal","year":"2017","journal-title":"Anticancer Res"},{"key":"2024022400024408200_znad377-B6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1471-2407-14-272","article-title":"Second primary cancer risk\u2014the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study","volume":"14","author":"Coyte","year":"2014","journal-title":"BMC Cancer"},{"key":"2024022400024408200_znad377-B7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/bju.13351","article-title":"Trends in the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10 047 patients","volume":"118","author":"Muller","year":"2016","journal-title":"BJU Int"},{"key":"2024022400024408200_znad377-B8","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jamcollsurg.2003.07.014","article-title":"Outcomes of active operation during intensive follow-up for second primary malignancy after esophagectomy for thoracic squamous cell esophageal carcinoma","volume":"197","author":"Motoyama","year":"2003","journal-title":"J Am Coll Surg"},{"key":"2024022400024408200_znad377-B9","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1158\/1055-9965.EPI-07-2876","article-title":"Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries","volume":"17","author":"Chuang","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2024022400024408200_znad377-B10","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s10147-018-1258-7","article-title":"Type of second primary malignancy after achieving complete response by definitive chemoradiation therapy in patients with esophageal squamous cell carcinoma","volume":"23","author":"Yamaguchi","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"2024022400024408200_znad377-B11","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.21037\/tcr-20-1105","article-title":"Incidence features of second primary malignancy among gastric cancer survivors, 1992\u20132012","volume":"9","author":"Li","year":"2020","journal-title":"Transl Cancer Res"},{"key":"2024022400024408200_znad377-B12","doi-asserted-by":"crossref","first-page":"7480","DOI":"10.3748\/wjg.v20.i23.7480","article-title":"Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study","volume":"20","author":"\u0141awniczak","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2024022400024408200_znad377-B13","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jaad.2020.06.1033","article-title":"Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer","volume":"85","author":"Goyal","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2024022400024408200_znad377-B14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10549-015-3456-6","article-title":"The association between breast cancer and thyroid cancer: a meta-analysis","volume":"152","author":"Joseph","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"2024022400024408200_znad377-B15"},{"key":"2024022400024408200_znad377-B16","first-page":"89","article-title":"The etiology of second primary neoplasms","volume":"12","author":"Kaiser","year":"1998","journal-title":"In Vivo"},{"key":"2024022400024408200_znad377-B17","first-page":"31","article-title":"Determination of sample size in using central limit theorem for Weibull distribution","volume":"17","author":"Chang","year":"2006","journal-title":"Int J Inform Manag Sci"},{"key":"2024022400024408200_znad377-B18"},{"key":"2024022400024408200_znad377-B19"},{"key":"2024022400024408200_znad377-B20","author":"Zhou","year":"2022"},{"key":"2024022400024408200_znad377-B21","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.3390\/cancers14194919","article-title":"Second primary malignancy risk in multiple myeloma from 1975 to 2018","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2024022400024408200_znad377-B22"},{"key":"2024022400024408200_znad377-B23","first-page":"631","article-title":"Multiple primary cancers in women with gynaecological malignancies: a cancer registry-based study in Umbria region of Italy","volume":"35","author":"Petrucci","year":"2014","journal-title":"Eur J Gynaecol Oncol"},{"key":"2024022400024408200_znad377-B24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000010212","article-title":"Overexpression of p53 and HER-2\/neu and c-myc in primary fallopian tube carcinoma","volume":"49","author":"Chung","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"2024022400024408200_znad377-B25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ccr.2011.08.023","article-title":"The metabolic regulator ERR\u03b1, a downstream target of HER2\/IGF-1R, as a therapeutic target in breast cancer","volume":"20","author":"Chang","year":"2011","journal-title":"Cancer Cell"},{"key":"2024022400024408200_znad377-B26","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2147\/CLEP.S174173","article-title":"Familial risks of second primary cancers and mortality in ovarian cancer patients","volume":"10","author":"Zheng","year":"2018","journal-title":"Clin Epidemiol"},{"key":"2024022400024408200_znad377-B27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/cam4.1899","article-title":"Second primary cancer after female breast cancer: familial risks and cause of death","volume":"8","author":"Zheng","year":"2019","journal-title":"Cancer Med"},{"key":"2024022400024408200_znad377-B28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10549-007-9759-5","article-title":"Modification of risk for subsequent cancer after female breast cancer by a family history of breast cancer","volume":"111","author":"Hemminki","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"2024022400024408200_znad377-B29","first-page":"793","article-title":"Second primary cancers after sporadic and familial colorectal cancer","volume":"10","author":"Hemminki","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2024022400024408200_znad377-B30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3857\/roj.2018.00290","article-title":"Radiation induced secondary malignancies: a review article","volume":"36","author":"Dracham","year":"2018","journal-title":"Radiat Oncol J"},{"key":"2024022400024408200_znad377-B31","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024022400024408200_znad377-B32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12967-022-03544-y","article-title":"Association between postoperative radiotherapy for young-onset head and neck cancer and long-term risk of second primary malignancy: a population-based study","volume":"20","author":"Zhu","year":"2022","journal-title":"J Transl Med"},{"key":"2024022400024408200_znad377-B33","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ijc.23798","article-title":"Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries","volume":"123","author":"Chuang","year":"2008","journal-title":"Int J Cancer"},{"key":"2024022400024408200_znad377-B34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/oxfordjournals.aje.a117154","article-title":"Malignancies that occur before and after anal cancer: clues to their etiology","volume":"140","author":"Frisch","year":"1994","journal-title":"Am J Epidemiol"},{"key":"2024022400024408200_znad377-B35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00004836-200605000-00008","article-title":"Association of esophageal adenocarcinoma with other subsequent primary cancers","volume":"40","author":"Das","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"2024022400024408200_znad377-B36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10552-019-01161-7","article-title":"Second primary lung cancer in United States cancer survivors, 1992\u20132008","volume":"30","author":"Donin","year":"2019","journal-title":"Cancer Causes Control"},{"key":"2024022400024408200_znad377-B37","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/91.8.708","article-title":"Tobacco smoking as a risk factor in anal carcinoma: an antiestrogenic mechanism?","volume":"91","author":"Frisch","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2024022400024408200_znad377-B38","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/j.gastro.2016.07.040","article-title":"Alcohol consumption and multiple dysplastic lesions increase risk of squamous cell carcinoma in the esophagus, head, and neck","volume":"151","author":"Katada","year":"2016","journal-title":"Gastroenterology"},{"key":"2024022400024408200_znad377-B39","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","article-title":"Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin","volume":"6","author":"Slaughter","year":"1953","journal-title":"Cancer"},{"key":"2024022400024408200_znad377-B40","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3389\/fonc.2019.01275","article-title":"Susceptibility of multiple primary cancers in patients with head and neck cancer: nature or nurture?","volume":"9","author":"Zhang","year":"2019","journal-title":"Front Oncol"},{"key":"2024022400024408200_znad377-B41","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/carcin\/bgn062","article-title":"Gene\u2013environment interaction in tobacco-related cancers","volume":"29","author":"Taioli","year":"2008","journal-title":"Carcinogenesis"},{"key":"2024022400024408200_znad377-B42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/dna.1996.15.273","article-title":"Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer","volume":"15","author":"Nebert","year":"1996","journal-title":"DNA Cell Biol"},{"key":"2024022400024408200_znad377-B43","first-page":"3","article-title":"Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers","volume":"9","author":"Bartsch","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2024022400024408200_znad377-B44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.canlet.2005.01.015","article-title":"The impact of genetic factors on the incidence of multiple primary tumours (MPT) of the head and neck","volume":"224","author":"Rydzanicz","year":"2005","journal-title":"Cancer Lett"},{"key":"2024022400024408200_znad377-B45","first-page":"3529","article-title":"Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study","volume":"22","author":"Wang","year":"2002","journal-title":"Anticancer Res"},{"key":"2024022400024408200_znad377-B46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3816\/CGC.2004.n.016","article-title":"Double primary cancers of the prostate and bladder: a literature review","volume":"3","author":"Kinoshita","year":"2004","journal-title":"Clin Prostate Cancer"},{"key":"2024022400024408200_znad377-B47","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/cncr.20714","article-title":"Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumours in patients with upper aerodigestive tract malignancies","volume":"101","author":"Do","year":"2004","journal-title":"Cancer"},{"key":"2024022400024408200_znad377-B48","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.juro.2012.11.075","article-title":"Brief smoking cessation intervention: a prospective trial in the urology setting","volume":"189","author":"Bjurlin","year":"2013","journal-title":"J Urol"},{"key":"2024022400024408200_znad377-B49","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1464-410X.1995.tb07352.x","article-title":"The role of tobacco in penile carcinoma","volume":"75","author":"Harish","year":"1995","journal-title":"Br J Urol"},{"key":"2024022400024408200_znad377-B50","first-page":"391","article-title":"Urothelial carcinoma: recurrence and risk factors","volume":"20","author":"Milojevic","year":"2015","journal-title":"J BUON"},{"key":"2024022400024408200_znad377-B51","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.urolonc.2020.01.008","article-title":"Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: are they clonally related? A systematic review","volume":"38","author":"van Doeveren","year":"2020","journal-title":"Urol Oncol"},{"key":"2024022400024408200_znad377-B52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12894-022-01158-6","article-title":"Presence of secondary bladder cancer following radical nephroureterectomy for upper tract urothelial carcinoma: characteristics, risk factors, and predictive value","volume":"22","author":"Lai","year":"2022","journal-title":"BMC Urol"},{"key":"2024022400024408200_znad377-B53","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/bju.14647","article-title":"Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes","volume":"123","author":"Belhadj","year":"2019","journal-title":"BJU Int"},{"key":"2024022400024408200_znad377-B54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2013.12.012","article-title":"PROBATE Group of GEC ESTRO. Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique","volume":"110","author":"Murray","year":"2014","journal-title":"Radiother Oncol"},{"key":"2024022400024408200_znad377-B55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/curroncol28010035","article-title":"The impact of radiotherapy on the incidence of secondary malignancies: a pan-cancer study in the US SEER Cancer Registries","volume":"28","author":"Li","year":"2021","journal-title":"Curr Oncol"},{"key":"2024022400024408200_znad377-B56","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/carcin\/21.3.427","article-title":"Hormonal carcinogenesis","volume":"21","author":"Henderson","year":"2000","journal-title":"Carcinogenesis"},{"key":"2024022400024408200_znad377-B57","first-page":"191","article-title":"Use of HRT and the subsequent risk of cancer","volume":"4","author":"Beral","year":"1999","journal-title":"J Epidemiol Biostat"},{"key":"2024022400024408200_znad377-B58","doi-asserted-by":"crossref","first-page":"e2018040","DOI":"10.4178\/epih.e2018040","article-title":"Androgen deprivation therapy is associated with decreased second primary lung cancer risk in the United States veterans with prostate cancer","volume":"40","author":"Jung","year":"2018","journal-title":"Epidemiol Health"},{"key":"2024022400024408200_znad377-B59","first-page":"1327","article-title":"The effects of steroid hormones on a human colon cancer cell line in vitro","volume":"12","author":"Lointier","year":"1992","journal-title":"Anticancer Res"},{"key":"2024022400024408200_znad377-B60","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.ejca.2007.05.015","article-title":"Age, sex and the risk of grade-specific second primary colorectal cancer: evidence for the protective effect of female hormone","volume":"43","author":"Liang","year":"2007","journal-title":"Eur J Cancer"},{"key":"2024022400024408200_znad377-B61","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/bjc.2013.219","article-title":"Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors","volume":"108","author":"Cooke","year":"2013","journal-title":"Br J Cancer"},{"key":"2024022400024408200_znad377-B62","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1200\/JCO.2005.01.7335","article-title":"Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design","volume":"23","author":"Prochazka","year":"2005","journal-title":"J Clin Oncol"},{"key":"2024022400024408200_znad377-B63","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/111\/1\/znad377\/56750265\/znad377.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/111\/1\/znad377\/56750265\/znad377.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:03:13Z","timestamp":1708732993000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/doi\/10.1093\/bjs\/znad377\/7459563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,6]]},"published-print":{"date-parts":[[2024,1,3]]}},"URL":"https:\/\/doi.org\/10.1093\/bjs\/znad377","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2023,12,6]]},"article-number":"znad377"}}